Charlotte Nichols MP: written questions
4 Jul 2025–3 Jul 2026
How these years work
Our reporting years run from 4 July to 3 July, starting with the 2024 general election. They are not official parliamentary sessions. Office costs keep IPSA’s April–March financial years. Records may cover only part of a year; a missing record does not mean no work was done.
Read what this MP said, asked and contributed in Parliament.
37 published records · newest first.
Written questions
Community Diagnostic CentresDepartment of Health and Social CareTabled 2 Jul 2026AnsweredUIN 15451More
Question: To ask the Secretary of State for Health and Social Care, with reference to the 10 Year Health Plan, what steps his Department is taking to encourage Integrated Care Boards to engage directly with independent providers of mobile diagnostic imaging service
Answer: The Government’s 10-Year Health Plan: Fit for the Future, encourages the shift from hospital to community. This includes bringing diagnostic services closer to patients’ homes and improving access to timely testing in community settings. Integrated care b...
Answered 16 Jul 2026
Original Parliament recordProcessed Food: LabellingDepartment of Health and Social CareTabled 10 Jun 2026AnsweredUIN 8640More
Question: To ask the Secretary of State for Health and Social Care, if he will make it his policy to mandate clear label markings on packaged food products to indicate excess a) salt, b) fat, c) sugar, d) trans and saturated fats and e) calories.
Answer: Food labelling legislation requires that pre-packaged food and drinks include a mandatory nutrition declaration, which provides information on energy, in kilojoules and kilocalories, and key nutrients, including fat, saturated fat, sugar and salt, in gram...
Answered 16 Jun 2026
Original Parliament recordProcessed Food: LabellingDepartment of Health and Social CareTabled 10 Jun 2026AnsweredUIN 8639More
Question: To ask the Secretary of State for Health and Social Care, if he will make it her policy to mandate clear labelling of ultra-processed food.
Answer: The Scientific Advisory Committee on Nutrition (SACN) has considered the impact of processed foods and health in 2023 and 2025. The limitations in the available evidence on processed and ultra-processed foods and health means it is unclear whether these f...
Answered 16 Jun 2026
Original Parliament recordHealth Services: Artificial IntelligenceDepartment of Health and Social CareTabled 20 May 2026AnsweredUIN 3410More
Question: To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the health costs caused by AI displacement in the workforce and associated stresses.
Answer: The Department has not made an estimate of the health costs caused by artificial intelligence (AI) related workforce displacement and associated stresses. AI is being deployed to reduce administrative burdens, support clinical decision-making, improve wor...
Answered 13 Jul 2026
Original Parliament recordNHS: Artificial IntelligenceDepartment of Health and Social CareTabled 21 Apr 2026AnsweredUIN 128815More
Question: To ask the Secretary of State for Health and Social Care, what estimate his Department has made of the increased health costs caused by AI displacement in the workforce and associated stresses; and if he will make a statement.
Answer: It has not proved possible to respond to the hon. Member in the time available before Prorogation.
Answered 29 Apr 2026
Original Parliament recordToothpaste: WomenDepartment of Health and Social CareTabled 6 Feb 2026AnsweredUIN 111443More
Question: To ask the Secretary of State for Health and Social Care, what steps he is taking to help ensure that women can access toothpaste that is appropriate for their saliva's ph level.
Answer: Toothpaste and other consumer healthcare products are widely available to support a range of oral hygiene needs, including those of women. The main modifiable risk factors for dental caries are diet, consuming too much sugar too often, and lack of optimal...
Answered 12 Feb 2026
Original Parliament recordCervical Cancer: ScreeningDepartment of Health and Social CareTabled 13 Jan 2026AnsweredUIN 105361More
Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of self-sampling on reaching under-screened populations for cervical cancer; and what estimate he has made of the uptake of (a) in-cl
Answer: The 10-Year Health Plan for England: Fit for the Future, restates the National Health Service’s aim to eliminate cervical cancer by 2040 through improved uptake of cervical screening and human papillomavirus (HPV) vaccination. Delivering the plan and maki...
Answered 21 Jan 2026
Original Parliament recordCervical Cancer: Health ServicesDepartment of Health and Social CareTabled 13 Jan 2026AnsweredUIN 105360More
Question: To ask the Secretary of State for Health and Social Care, if he will publish a delivery plan that includes (a) who is responsible for each of the actions in the Cervical cancer elimination by 2040 – plan for England, (b) when they will be delivered and (c
Answer: The 10-Year Health Plan for England: Fit for the Future restates the National Health Service’s aim to eliminate cervical cancer by 2040 through improved uptake of cervical screening and human papillomavirus (HPV) vaccination. Delivering the plan and makin...
Answered 21 Jan 2026
Original Parliament recordADHD: DiagnosisDepartment of Health and Social CareTabled 16 Dec 2025AnsweredUIN 100441More
Question: To ask the Secretary of State for Health and Social Care, what is the average waiting time for an ADHD assessment in a) England, b) the North West and c) the Cheshire and Merseyside Integrated Care Board area.
Answer: For the first time, NHS England published management information on attention deficit hyperactivity disorder (ADHD) waits at a national level on 29 May 2025 as part of its ADHD data improvement plan, and has also released technical guidance to integrated ...
Answered 13 Jan 2026
Original Parliament recordADHD: DiagnosisDepartment of Health and Social CareTabled 16 Dec 2025AnsweredUIN 100440More
Question: To ask the Secretary of State for Health and Social Care, how many people are on a waiting list for an ADHD assessment in a) England, b) the North West and c) the Cheshire and Merseyside Integrated Care Board area.
Answer: For the first time, NHS England published management information on attention deficit hyperactivity disorder (ADHD) waits at a national level on 29 May 2025 as part of its ADHD data improvement plan, and has also released technical guidance to integrated ...
Answered 13 Jan 2026
Original Parliament recordIVF: SurrogacyDepartment of Health and Social CareTabled 15 Dec 2025AnsweredUIN 99884More
Question: To ask the Secretary of State for Health and Social Care, what steps he is taking to ensure equitable access to funding for IVF surrogacy for people post cancer treatment.
Answer: Funding decisions for fertility services, including cases where a surrogate may be involved, are made by integrated care boards (ICBs), which are responsible for commissioning services based on the clinical needs of their populations. We expect ICBs to co...
Answered 22 Dec 2025
Original Parliament recordVorasidenibDepartment of Health and Social CareTabled 11 Dec 2025AnsweredUIN 99268More
Question: To ask the Secretary of State for Health and Social Care, when he expects the drug Vorsidenib (Voranigo) to be made available to treat adults and children aged 12 years and over with grade 2 astrocytoma or oligodendroglioma carrying a susceptible IDH1 or
Answer: The National Institute for Health and Care Excellence (NICE) is the independent body that makes evidence-based recommendations on whether new medicines should be routinely funded by the National Health Service based on an assessment of clinical and cost e...
Answered 18 Dec 2025
Original Parliament recordNaloxone: Public ConsultationDepartment of Health and Social CareTabled 24 Nov 2025AnsweredUIN 93958More
Question: To ask the Secretary of State for Health and Social Care, when he plans to publish a consultation on access to naloxone.
Answer: Naloxone is a lifesaving medicine that reverses the effects of an opioid overdose, including highly potent synthetic opioids which are growing in prevalence in the United Kingdom. It is more important than ever to increase access to naloxone products, whi...
Answered 19 Jan 2026
Original Parliament recordNaloxoneDepartment of Health and Social CareTabled 24 Nov 2025AnsweredUIN 93957More
Question: To ask the Secretary of State for Health and Social Care, what his planned timeline is for the establishment of the naloxone supply network coordinators.
Answer: Naloxone is a lifesaving medicine that reverses the effects of an opioid overdose, including highly potent synthetic opioids which are growing in prevalence in the United Kingdom. It is more important than ever to increase access to naloxone products, whi...
Answered 9 Dec 2025
Original Parliament recordCoronavirus: VaccinationDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88871More
Question: To ask the Secretary of State for Health and Social Care, when the database of AstraZeneca covid-19 vaccine side effects was last updated.
Answer: The Medicines and Healthcare products Regulatory Agency is responsible for monitoring all authorised medicines and vaccines in the United Kingdom, including the AstraZeneca COVID-19 vaccines, on an ongoing basis to ensure their benefits continue to outwei...
Answered 20 Nov 2025
Original Parliament recordVaccine Damage Payment SchemeDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88870More
Question: To ask the Secretary of State for Health and Social Care, what comparative assessment he has made of approval rates for covid-19 vaccine injury claims in (a) the UK and (b) other jurisdictions for which figures are available.
Answer: No specific assessment has been made. All claims made through the Vaccine Damage Payment Scheme are assessed on a case-by-case basis by independent medical assessors. Medical assessors must be General Medical Council registered doctors with a licence to p...
Answered 18 Nov 2025
Original Parliament recordVaccine Damage Payment SchemeDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88869More
Question: To ask the Secretary of State for Health and Social Care, what the rate for (a) approval of claims, (b) claims overturned at review and (c) payout has been for the Vaccine Damage Payment Scheme since March 2022.
Answer: The Vaccine Damage Payment Scheme (VDPS) provides a one-off, tax-free payment of £120,000 to claimants who have been found, in rare cases and on the balance of probabilities, to have been severely disabled by certain vaccines for a disease listed in the V...
Answered 18 Nov 2025
Original Parliament recordVaccinationDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88868More
Question: To ask the Secretary of State for Health and Social Care, what steps he is taking to make (a) apheresis and (b) immunoabsorption treatments available for vaccine damage patients when doctors feel it would be beneficial.
Answer: In the very rare event where an individual may have suffered a severe adverse reaction to a COVID-19 vaccine, care and treatment will be managed by National Health Service local specialist services, augmented as appropriate by national specialist advice, ...
Answered 19 Nov 2025
Original Parliament recordCoronavirus: VaccinationDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88867More
Question: To ask the Secretary of State for Health and Social Care, what steps his Department is taking to (a) approve and (b) fund specialist treatments for AstraZeneca vaccine damage.
Answer: In the very rare event where an individual may have suffered a severe adverse reaction to a COVID-19 vaccine, care and treatment will be managed by National Health Service local specialist services, augmented as appropriate by national specialist advice, ...
Answered 19 Nov 2025
Original Parliament recordCoronavirus: VaccinationDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88866More
Question: To ask the Secretary of State for Health and Social Care, whether his Department is undertaking research into (a) damage and (b) lasting effects from the AstraZeneca vaccine.
Answer: Vaccines are only authorised once they have met robust standards of effectiveness, safety, and quality set by the independent medicines’ regulator, the Medicines and Healthcare products Regulatory Agency (MHRA).The monitoring of vaccine safety does not st...
Answered 18 Nov 2025
Original Parliament recordVaccine Damage Payment SchemeDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88865More
Question: To ask the Secretary of State for Health and Social Care, what the medical experience requirements are for caseworkers handling vaccine damage payment claims.
Answer: Caseworkers supporting the Vaccine Damage Payment Scheme (VDPS) are administrative staff who are not involved in the assessment of claims. Their role is to provide claimants with a consistent point of contact, manage the administrative progress of claims,...
Answered 18 Nov 2025
Original Parliament recordCoronavirus: VaccinationDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88864More
Question: To ask the Secretary of State for Health and Social Care, how often the database of AstraZeneca covid vaccine side effects has been updated in each year since 2020.
Answer: The Medicines and Healthcare products Regulatory Agency is responsible for monitoring all authorised medicines and vaccines in the United Kingdom, including the AstraZeneca COVID-19 vaccines, on an ongoing basis to ensure their benefits continue to outwei...
Answered 20 Nov 2025
Original Parliament recordCoronavirus: VaccinationDepartment of Health and Social CareTabled 10 Nov 2025AnsweredUIN 88863More
Question: To ask the Secretary of State for Health and Social Care, what research his Department is undertaking into side affects of the AstraZenica covid vaccine; through what process his Department are recognising emerging side effects; and if he will make a stat
Answer: Vaccines are only authorised once they have met robust standards of effectiveness, safety, and quality set by the independent medicines’ regulator, the Medicines and Healthcare products Regulatory Agency (MHRA).The monitoring of vaccine safety does not st...
Answered 18 Nov 2025
Original Parliament recordCervical Cancer: ScreeningDepartment of Health and Social CareTabled 30 Oct 2025AnsweredUIN 86736More
Question: To ask the Secretary of State for Health and Social Care, what assessment his Department has made of the potential impact of cervical cancer self-sampling on reaching under-screened populations; and what targets he has for the uptake of (a) in-clinic and
Answer: Both the impact assessment and the equality impact assessment on the introduction of human papillomavirus (HPV) self-sampling for the under-screened population in the National Health Service Cervical Screening Programme have been published and is availabl...
Answered 5 Nov 2025
Original Parliament recordCervical Cancer: Health ServicesDepartment of Health and Social CareTabled 30 Oct 2025AnsweredUIN 86735More
Question: To ask the Secretary of State for Health and Social Care, with reference to NHS England's plan entitled Cervical cancer elimination by 2040 – plan for England, published on 28 March 2025, if his Department will set out (a) who is responsible for each of t
Answer: The Government is committed to improving vaccine uptake and access across all immunisation programmes by exploring new and innovative delivery models, including expanding routes such as community pharmacies, as set out in the NHS Vaccination Strategy and ...
Answered 1 Dec 2025
Original Parliament record
Explore activity by topic or department
Written questions by answering department
4 Jul 2025–3 Jul 2026. One record per UIN and tabled date; the named department is not a measure of answer quality.
View as listWhat this shows and doesn't show
Published records only — not a full account of an MP’s work. How we work →